目前,仍以溶栓、降纤、抗凝及脑保护剂等治疗为主,参考有关资料,现对其近况综述如下。1 溶栓治疗脑缺血半暗带的理论及其深入研究结果,是急性脑梗死溶栓治疗的重要基础。按给药途径不同可分为动脉和静脉溶栓两种方法、至于何种用药途径疗效更佳,目前尚无完全定论。但是近年来国外有研究表明急性缺血性脑血管病局部动脉内溶栓治疗(LIF)较静脉溶栓血管再通率相对高,颅内出血率低,临床疗效好。 At present, still thrombolytic, fibrinolytic, anticoagulant and brain protective agents such as treatment-based, with reference to the relevant information, are summarized as follows. 1 thrombolytic therapy of cerebral ischemic penumbra theory and its in-depth study, is an important basis for thrombolytic therapy of acute cerebral infarction. According to different routes of administration can be divided into two methods of arterial and intravenous thrombolysis, as for which route of administration of better efficacy, there is no conclusive. However, in recent years, foreign studies have shown that intra-arterial thrombolysis in acute ischemic cerebrovascular disease (LIF) is relatively higher than the recanalization rate of intravenous thrombolysis, low intracranial hemorrhage and good clinical efficacy.